Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
33.40
-0.50 (-1.47%)
May 14, 2026, 4:00 PM EDT

SHA:688139 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,2802,3162,2742,2722,8552,119
Other Revenue
12.212.29.859.248.627.31
2,2922,3292,2842,2812,8642,126
Revenue Growth (YoY)
0.26%1.96%0.13%-20.36%34.72%51.63%
Cost of Revenue
1,2331,2471,1901,1741,4901,061
Gross Profit
1,0591,0821,0941,1071,3741,065
Selling, General & Admin
561.22552.22471.73476.68513.72388.03
Research & Development
326.79323.25306.17320.64292.47236.31
Other Operating Expenses
-7.57-2.74-6.48-7.252.341.63
Operating Expenses
893.59885.88787.08793.97809.08622.71
Operating Income
164.97195.77306.58312.95564.67441.98
Interest Expense
-3.91-3.91-3.41-3.51-2.69-2.89
Interest & Investment Income
57.7562.6871.46118.6495.02483.95
Currency Exchange Gain (Loss)
-2.38-2.384.46-7.723.584.14
Other Non Operating Income (Expenses)
-9.94-3.44-1.87-1.64-1.490.56
EBT Excluding Unusual Items
206.49248.72377.21418.71659.1927.74
Gain (Loss) on Sale of Investments
-0.22-0.495.472.06-7.0110.21
Gain (Loss) on Sale of Assets
0.670.630.23-1.6-0.76-0.52
Asset Writedown
-0.2-1.23-1.86-2.36--
Other Unusual Items
17.1317.1320.917.692423.44
Pretax Income
223.88264.76401.96434.49675.34960.87
Income Tax Expense
4.959.6320.9522.4363.36111.7
Earnings From Continuing Operations
218.92255.13381.01412.06611.97849.17
Minority Interest in Earnings
1.01-4.4-14.38-5.99-11.18-4.14
Net Income
219.93250.73366.63406.07600.79845.04
Net Income to Common
219.93250.73366.63406.07600.79845.04
Net Income Growth
-35.18%-31.61%-9.71%-32.41%-28.90%121.82%
Shares Outstanding (Basic)
314313316317318316
Shares Outstanding (Diluted)
314313316317318318
Shares Change (YoY)
-0.79%-0.84%-0.37%-0.20%0.06%-2.43%
EPS (Basic)
0.700.801.161.281.892.67
EPS (Diluted)
0.700.801.161.281.892.66
EPS Growth
-34.66%-31.03%-9.38%-32.27%-28.95%127.35%
Free Cash Flow
135.62148.64164.9672.08338.18387.11
Free Cash Flow Per Share
0.430.470.520.231.061.22
Dividend Per Share
0.3300.3300.4700.5150.4500.500
Dividend Growth
-29.79%-29.79%-8.74%14.44%-10.02%31.61%
Gross Margin
46.19%46.45%47.89%48.53%47.97%50.08%
Operating Margin
7.20%8.41%13.42%13.72%19.72%20.79%
Profit Margin
9.60%10.77%16.05%17.80%20.98%39.75%
Free Cash Flow Margin
5.92%6.38%7.22%3.16%11.81%18.21%
EBITDA
270.9303.74422.71410.67626.73491.15
EBITDA Margin
11.82%13.04%18.51%18.00%21.88%23.10%
D&A For EBITDA
105.93107.97116.1397.7262.0649.17
EBIT
164.97195.77306.58312.95564.67441.98
EBIT Margin
7.20%8.41%13.42%13.72%19.72%20.79%
Effective Tax Rate
2.21%3.64%5.21%5.16%9.38%11.63%
Revenue as Reported
2,3292,3292,2842,2812,8642,126
Advertising Expenses
-35.1624.8831.8225.4114.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.